MetaADEDB 2.0 @ LMMD
Vildagliptin
(SYOKIDBDQMKNDQ-XWTIBIIYSA-N)
Structure
SMILES
N#C[C@@H]1CCCN1C(=O)CNC12CC3CC(C1)CC(C2)(C3)O
Type(s)
Approved; Investigational
ATC code(s)
A10BD08; A10BH02
Molecular Formula:
C17H25N3O2
Molecular Weight:
303.399
Log P:
1.5031
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
76.36
CAS Number(s):
274901-16-5
Synonym(s)
1.
Vildagliptin
2.
(2S)-(((3-Hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile
3.
Galvus
4.
NVP-LAF237
5.
NVP LAF237
External Link(s)
MeSHD000077597
PubChem Compound6918537
BindingDB11695
ChEBI135285
CHEMBLCHEMBL142703
DrugBankDB04876
DrugCentral3642
IUPHAR/BPS Guide to PHARMACOLOGY6310
KEGGdr:D07080
Therapeutic Target DatabaseD0L3DK
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1BlindnessFAERS: 1US FAERS
2Diabetes mellitus inadequate controlFAERS: 1OFFSIDES
US FAERS
3Hepatic InfectionFAERS: 1US FAERS
4Intraductal papillary-mucinous carcinoma of pancreasFAERS: 1US FAERS
5PancreatitisFAERS: 1SIDER
US FAERS
6Abdominal PainOFFSIDES
7AdenocarcinomaOFFSIDES
8AngioedemaSIDER
9AngioplastyOFFSIDES
10ArthralgiaSIDER
11ArthropathyOFFSIDES
12AstheniaSIDER
13Blood GlucoseOFFSIDES
14Blood creatinine increasedOFFSIDES
15Blood glucose decreasedSIDER
16Blood glucose fluctuationOFFSIDES
17Blood pressure fluctuationOFFSIDES
18Blood pressure inadequately controlledOFFSIDES
19BradycardiaOFFSIDES
20Bulbar palsyOFFSIDES
21Catheter placementOFFSIDES
22ChillsSIDER
23Cognition Disorders28807765CTD
24Cold sweatOFFSIDES
25Concomitant disease progressionOFFSIDES
26ConstipationSIDER
27CystOFFSIDES
28DehydrationOFFSIDES
29DizzinessSIDER
30DrowsinessOFFSIDES
31Drug administration errorOFFSIDES
32DysuriaOFFSIDES
33EmbolismOFFSIDES
34EpistaxisOFFSIDES
35FatigueSIDER
36Feeling ColdOFFSIDES
37FlatulenceSIDER
38FormicationOFFSIDES
39GlaucomaOFFSIDES
40HeadacheSIDER
41HemiplegiaOFFSIDES
42HepatitisSIDER
43InfectionSIDER
44InfestationSIDER
45Insulin Resistance28807765CTD
46Joint Range of Motion DecreasedOFFSIDES
47LethargyOFFSIDES
48Limb discomfortOFFSIDES
49MalnutritionSIDER
50MonoplegiaOFFSIDES
51Musculoskeletal discomfortSIDER
52NasopharyngitisSIDER
53NauseaSIDER
54PallorOFFSIDES
55PanophthalmitisOFFSIDES
56ScabOFFSIDES
57Septic ShockOFFSIDES
58Skin lesionOFFSIDES
59TremorSIDER
60UrticariaSIDER
61Vascular stent insertionOFFSIDES
62effusionOFFSIDES
63nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.